Pharma sector study: CCI starts consultation process with companies, doctors, other stakeholders

By: |
February 19, 2021 5:58 PM

"The idea behind the consultation is to gather insights on issues that may have a bearing on competition in the pharmaceutical market in India," the regulator said in a public notice.

The watchdog, which keeps a tab on unfair business practices across sectors, started the market study on the domestic pharmaceutical sector in October last year.The watchdog, which keeps a tab on unfair business practices across sectors, started the market study on the domestic pharmaceutical sector in October last year.

The Competition Commission of India (CCI) on Friday started a consultation process to gather views from pharmaceutical companies, doctors and other stakeholders as part of its ongoing study on the country’s pharmaceutical sector.

The watchdog, which keeps a tab on unfair business practices across sectors, started the market study on the domestic pharmaceutical sector in October last year.

The study is being done with a view to developing a better understanding of the competition landscape in the sector.

“As part of the study, the CCI is conducting consultation with stakeholders (pharmaceutical companies, stockists, chemists, trade associations, doctors, sector experts and regulators).

“The idea behind the consultation is to gather insights on issues that may have a bearing on competition in the pharmaceutical market in India,” the regulator said in a public notice.

The current study is focussing on the distribution segment of the pharmaceutical market in India with a view to understanding discounts, margins, policies at wholesale and retail levels of the distribution system, the role of trade association vis-a-vis various aspects of the distribution business, impact of e-commerce on price and competition, among other aspects.

In December last year, CCI Chairperson Ashok Kumar Gupta had said that quality, access and affordability of medicines are the key determinants for the overall quality of public health.

However, owing to the inherited information asymmetry in consumers and suppliers for medicines, markets by themselves may not deliver optimal outcomes in terms of these parameters, he had said.

CCI has been conducting various market studies to understand competition issues in different sectors.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Tremendous potential for proliferation of public Wi-Fi hotspots in India: Trai Chief
2From new layouts to guided meditation exercises, Microsoft Teams, Viva get updates for hybrid work mode
3Air India to sell real estate assets; may garner up to Rs 300 cr